Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Undervalued stocks
Momentum stocks
ESG stocks
Yield stocks
Growth stocks
Quality stocks
Investment Themes
Gold and Silver
Education
The Cannabis Industry
The future of mobility
Biotechnology
Boats
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Fintechs
Biotechnology
The SPAC
The Golden Age of Video Games
Artificial Intelligence
Financial Data
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
News
Accueil
Business Leaders Biography
Business Leaders
Latest News
Companies
Markets
Economy & Forex
Commodities
Interest Rates
Business Leaders
Finance Pro.
Calendar
Sectors
Home
All News
Most read news
Business Leaders Biography
Patrick D. Kirwin
Public asset :
341,978 USD
Linked companies :
ProMIS Neurosciences, Inc.
Summary
Patrick D. Kirwin is on the board of ProMIS Neurosciences, Inc. and Senior Partner at Kirwin LLP.
Mr. Kirwin received an undergraduate degree from the University of Alberta and a graduate degree from the University of Toronto.
Current positions of Patrick D. Kirwin
Name
Title
Since
ProMIS Neurosciences, Inc.
Independent Director
2015
Kirwin LLP
Senior Partner
1986
Holdings of Patrick D. Kirwin
Name
Equities
%
Valuation
ProMIS Neurosciences Inc.
3,799,750
0.88%
341,978 USD
Patrick D. Kirwin: Personal Network
Name
Linked companies
Josh Mandel-Brehm
ProMIS Neurosciences, Inc.
Eugene Williams
ProMIS Neurosciences, Inc.
Larry Douglas Altstiel
ProMIS Neurosciences, Inc.
Richard James Gregory
ProMIS Neurosciences, Inc.
Gavin T. Malenfant
ProMIS Neurosciences, Inc.
Johanne Kaplan
ProMIS Neurosciences, Inc.
David Wishart
ProMIS Neurosciences, Inc.
Dennis Chen
ProMIS Neurosciences, Inc.
Maggie Shafmaster
ProMIS Neurosciences, Inc.
Daniel E. Geffken
ProMIS Neurosciences, Inc.
Most Read News
06/22
ELON MUSK
: Musk says Tesla's new car factories 'losing billions of dollars'
RE
06/15
ELON MUSK
: Elon Musk appeals decision concerning SEC settlement over Twitter posts
RE
06/23
MARK MILLER
: Column-Want to do something about your ailing retirement savings? Don't
RE
06/22
TREVOR MILTON
: Nikola founder Trevor Milton faces new fraud charge
RE
06/13
ELON MUSK
: Musk to attend Twitter staff Q&A meet for first time since launching bid
RE
06/13
BENEDETTO VIGNA
: Vigna to set out Ferrari's route into electric vehicle era
RE
06/22
RUPERT MURDOCH
: Rupert Murdoch and Jerry Hall are getting a divorce - NYT
RE
06/15
PETER WENNINK
: Samsung's Lee discusses smooth supply of "essential" chip equipment with ASML's Wennink
RE
06/14
HAROLD HAMM
: Billionaire-founder Harold Hamm offers to take Continental private in $25-billion deal
RE
06/21
ELON MUSK
: Musk says there are still a few unresolved matters with Twitter deal
RE
More news
© 2022 People and Ownership :
Patrick D. Kirwin : Connections
HOMOLOGY MEDICINES, INC.
Richard James Gregory
ELOXX PHARMACEUTICALS, INC.
Daniel E. Geffken
OPY ACQUISITION CORP. I
Daniel E. Geffken
PHOENIX BIOTECH ACQUISITION CORP.
Daniel E. Geffken
WINDTREE THERAPEUTICS, INC.
Daniel E. Geffken
CANBRIDGE PHARMACEUTICALS INC.
Richard James Gregory
Slave